Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study.
Dauvilliers Y, Craig SE, Bonsignore MR, Barbé F, Verbraecken J, Asin J, Georgiev O, Tiholov R, Caussé C, Lecomte JM, Schwartz JC, Lehert P, Randerath W, Pépin JL; HAROSA III Study Group.
Dauvilliers Y, et al. Among authors: schwartz jc.
J Sleep Res. 2024 Oct 8:e14373. doi: 10.1111/jsr.14373. Online ahead of print.
J Sleep Res. 2024.
PMID: 39377364